marketcaparena
Search

    Largest companies by net assets

    net assets
    Clear
    Companies ranked by net assets, in USD
    CompanyNet assetsSectorIndustryCountryExchange
    301MIRMMirum Pharmaceuticals, Inc.$-10.42MHealthcarePharmaceuticalsUnited StatesNasdaq
    302OSTXOS Therapies Inc$-11.91MHealthcarePharmaceuticalsUnited StatesNYSE
    303AEONAEON Biopharma, Inc.$-15.36MHealthcarePharmaceuticalsUnited StatesNYSE
    304NTHINEONC TECHNOLOGIES HOLDINGS, INC.$-18.53MHealthcarePharmaceuticalsUnited StatesNasdaq
    305CLNNClene Inc.$-24.78MHealthcarePharmaceuticalsUnited StatesNasdaq
    306RNAZTranscode Therapeutics, Inc.$-27.69MHealthcarePharmaceuticalsUnited StatesNasdaq
    307KYNBKYNTRA BIO, INC.$-30.14MHealthcarePharmaceuticalsUnited StatesNasdaq
    308EOLSEvolus, Inc.$-30.90MHealthcarePharmaceuticalsUnited StatesNasdaq
    309LFCRLIFECORE BIOMEDICAL, INC. \DE\$-34.09MHealthcarePharmaceuticalsUnited StatesNasdaq
    310BYSIBeyondSpring Inc.$-35.57MHealthcarePharmaceuticalsUnited StatesNasdaq
    311ADILADIAL PHARMACEUTICALS, INC.$-38.38MHealthcarePharmaceuticalsUnited StatesNasdaq
    312OMEROMEROS CORP$-51.35MHealthcarePharmaceuticalsUnited StatesNasdaq
    313AQSTAquestive Therapeutics, Inc.$-56.59MHealthcarePharmaceuticalsUnited StatesNasdaq
    314FHTXFoghorn Therapeutics Inc.$-81.04MHealthcarePharmaceuticalsUnited StatesNasdaq
    315GOSSGossamer Bio, Inc.$-94.03MHealthcarePharmaceuticalsUnited StatesNasdaq
    316BRVEBraveheart Bio, Inc.$-95.91MHealthcarePharmaceuticals—Nasdaq
    317RNACCartesian Therapeutics, Inc.$-125.23MHealthcarePharmaceuticalsUnited StatesNasdaq
    318URGNUroGen Pharma Ltd.$-132.40MHealthcarePharmaceuticalsUnited StatesNasdaq
    319GALTGALECTIN THERAPEUTICS INC$-138.57MHealthcarePharmaceuticalsUnited StatesNasdaq
    320IRWDIRONWOOD PHARMACEUTICALS INC$-161.84MHealthcarePharmaceuticalsUnited StatesNasdaq
    321PTCTPTC THERAPEUTICS, INC.$-165.36MHealthcarePharmaceuticalsUnited StatesNasdaq
    322CYTKCYTOKINETICS INC$-173.49MHealthcarePharmaceuticalsUnited StatesNasdaq
    323BLSMBlossomHill Therapeutics, Inc.$-174.78MHealthcarePharmaceuticals—Nasdaq
    324APMDApnimed, Inc.$-176.18MHealthcarePharmaceuticals—Nasdaq
    325INDVIndivior Pharmaceuticals, Inc.$-208.00MHealthcarePharmaceuticalsUnited StatesNasdaq
    326NERVMinerva Neurosciences, Inc.$-213.30MHealthcarePharmaceuticalsUnited StatesNasdaq
    327ADCTADC Therapeutics SA$-228.21MHealthcarePharmaceuticalsUnited StatesNYSE
    328LTGOLatigo Biotherapeutics, Inc.$-276.08MHealthcarePharmaceuticals—Nasdaq
    329RAREUltragenyx Pharmaceutical Inc.$-291.00MHealthcarePharmaceuticalsUnited StatesNasdaq
    330KPTIKaryopharm Therapeutics Inc.$-330.17MHealthcarePharmaceuticalsUnited StatesNasdaq
    331PHATPhathom Pharmaceuticals, Inc.$-344.27MHealthcarePharmaceuticalsUnited StatesNasdaq
    332BBIOBridgeBio Pharma, Inc.$-2.52BHealthcarePharmaceuticalsUnited StatesNasdaq
    333ABBVAbbVie Inc.$-5.93BHealthcarePharmaceuticalsUnited StatesNYSE

    U.S.-exchange common stocks; ADRs and funds excluded. 333 companies. Reported USD values. TTM means trailing twelve months; companies without a comparable value are excluded.